Allianz Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $431M | Sell |
3,094,227
-936,303
| -23% | -$131M | 0.45% | 34 |
|
|
2025
Q4 | $495M | Sell |
4,030,530
-1,742,489
| -30% | -$212M | 0.5% | 26 |
|
|
2025
Q3 | $641M | Sell |
5,773,019
-451,098
| -7% | -$51.3M | 0.72% | 18 |
|
|
2025
Q2 | $690M | Buy |
6,224,117
+438,200
| +8% | +$46.6M | 0.83% | 14 |
|
|
2025
Q1 | $648M | Buy |
5,785,917
+676,824
| +13% | +$69.8M | 0.85% | 16 |
|
|
2024
Q4 | $472M | Buy |
5,109,093
+783,538
| +18% | +$70.5M | 0.63% | 20 |
|
|
2024
Q3 | $363M | Buy |
4,325,555
+107,066
| +3% | +$8.17M | 0.51% | 33 |
|
|
2024
Q2 | $289M | Sell |
4,218,489
-95,091
| -2% | -$6.35M | 0.43% | 41 |
|
|
2024
Q1 | $316M | Buy |
4,313,580
+89,105
| +2% | +$6.85M | 0.49% | 43 |
|
|
2023
Q4 | $342M | Buy |
4,224,475
+248,618
| +6% | +$19.3M | 0.56% | 32 |
|
|
2023
Q3 | $298M | Buy |
3,975,857
+237,498
| +6% | +$18.3M | 0.5% | 41 |
|
|
2023
Q2 | $288M | Buy |
3,738,359
+564,888
| +18% | +$45.1M | 0.52% | 38 |
|
|
2023
Q1 | $263M | Buy |
3,173,471
+138,997
| +5% | +$11.5M | 0.47% | 36 |
|
|
2022
Q4 | $261M | Sell |
3,034,474
-649,647
| -18% | -$51.4M | 0.51% | 34 |
|
|
2022
Q3 | $227M | Sell |
3,684,121
-295,680
| -7% | -$18.6M | 0.46% | 40 |
|
|
2022
Q2 | $246M | Sell |
3,979,801
-51,620
| -1% | -$3.2M | 0.23% | 100 |
|
|
2022
Q1 | $240M | Sell |
4,031,421
-147,695
| -4% | -$9.44M | 0.18% | 133 |
|
|
2021
Q4 | $304M | Sell |
4,179,116
-205,749
| -5% | -$14.2M | 0.21% | 106 |
|
|
2021
Q3 | $306M | Buy |
4,384,865
+3,242,180
| +284% | +$228M | 0.24% | 94 |
|
|
2021
Q2 | $78.7M | Sell |
1,142,685
-312,188
| -21% | -$20.8M | 0.07% | 281 |
|
|
2021
Q1 | $94M | Buy |
1,454,873
+143,830
| +11% | +$9.27M | 0.09% | 226 |
|
|
2020
Q4 | $76.4M | Buy |
1,311,043
+222,317
| +20% | +$13.4M | 0.08% | 261 |
|
|
2020
Q3 | $68.8M | Sell |
1,088,726
-1,518,823
| -58% | -$105M | 0.08% | 258 |
|
|
2020
Q2 | $201M | Sell |
2,607,549
-844,813
| -24% | -$64.7M | 0.23% | 98 |
|
|
2020
Q1 | $258M | Sell |
3,452,362
-191,630
| -5% | -$13.2M | 0.35% | 52 |
|
|
2019
Q4 | $237M | Sell |
3,643,992
-44,395
| -1% | -$2.89M | 0.22% | 98 |
|
|
2019
Q3 | $234M | Sell |
3,688,387
-671,394
| -15% | -$43.9M | 0.23% | 86 |
|
|
2019
Q2 | $295M | Sell |
4,359,781
-201,207
| -4% | -$13.2M | 0.27% | 66 |
|
|
2019
Q1 | $297M | Sell |
4,560,988
-222,895
| -5% | -$14.8M | 0.29% | 63 |
|
|
2018
Q4 | $299M | Buy |
4,783,883
+249,140
| +5% | +$17.4M | 0.33% | 56 |
|
|
2018
Q3 | $350M | Buy |
4,534,743
+605,846
| +15% | +$45.8M | 0.32% | 57 |
|
|
2018
Q2 | $278M | Sell |
3,928,897
-448,179
| -10% | -$31.6M | 0.27% | 63 |
|
|
2018
Q1 | $330M | Sell |
4,377,076
-733,168
| -14% | -$58.3M | 0.31% | 53 |
|
|
2017
Q4 | $366M | Buy |
5,110,244
+597,615
| +13% | +$45.4M | 0.29% | 58 |
|
|
2017
Q3 | $366M | Buy |
4,512,629
+466,059
| +12% | +$35.6M | 0.32% | 46 |
|
|
2017
Q2 | $287M | Buy |
4,046,570
+420,400
| +12% | +$28M | 0.28% | 58 |
|
|
2017
Q1 | $246M | Sell |
3,626,170
-1,054,219
| -23% | -$74.1M | 0.24% | 67 |
|
|
2016
Q4 | $335M | Buy |
4,680,389
+338,408
| +8% | +$25.2M | 0.3% | 47 |
|
|
2016
Q3 | $342M | Sell |
4,341,981
-2,792,872
| -39% | -$227M | 0.33% | 49 |
|
|
2016
Q2 | $595M | Buy |
7,134,853
+262,429
| +4% | +$23.3M | 0.63% | 21 |
|
|
2016
Q1 | $631M | Buy |
6,872,424
+154,047
| +2% | +$13.9M | 0.72% | 20 |
|
|
2015
Q4 | $681M | Buy |
6,718,377
+250,282
| +4% | +$26M | 0.77% | 18 |
|
|
2015
Q3 | $635M | Buy |
6,468,095
+232,147
| +4% | +$25.8M | 0.76% | 23 |
|
|
2015
Q2 | $731M | Buy |
6,235,948
+2,471,418
| +66% | +$270M | 0.78% | 13 |
|
|
2015
Q1 | $369M | Sell |
3,764,530
-784,536
| -17% | -$79.7M | 0.42% | 53 |
|
|
2014
Q4 | $429M | Sell |
4,549,066
-391,845
| -8% | -$40.5M | 0.48% | 40 |
|
|
2014
Q3 | $526M | Sell |
4,940,911
-48,505
| -1% | -$4.75M | 0.63% | 25 |
|
|
2014
Q2 | $414M | Sell |
4,989,416
-258,041
| -5% | -$20.1M | 0.52% | 39 |
|
|
2014
Q1 | $372M | Buy |
5,247,457
+282,645
| +6% | +$22.2M | 0.45% | 46 |
|
|
2013
Q4 | $373M | Buy |
4,964,812
+718,702
| +17% | +$50M | 0.48% | 51 |
|
|
2013
Q3 | $267M | Buy |
4,246,110
+1,020,941
| +32% | +$61M | 0.35% | 68 |
|
|
2013
Q2 | $165M | Buy |
+3,225,169
| New | +$168M | 0.23% | 94 |
|
Other funds holding GILD
VCM
VPM
Allianz Asset Management's GILD Position: Q1 2026 in Review
Allianz Asset Management reduced its Gilead Sciences (GILD) stake by 23% in Q1 2026, selling an estimated $131M and leaving 3,094,227 shares worth $431M. The position accounts for 0.45% of the portfolio, ranked #34.
Allianz Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $731M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Allianz Asset Management held 3,094,227 shares of Gilead Sciences worth $431M as of Q1 2026.
- Allianz Asset Management sold 936,303 Gilead Sciences shares in Q1 2026, an estimated $131M.
- Gilead Sciences made up 0.45% of Allianz Asset Management's portfolio in Q1 2026, its #34 holding.
- Allianz Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Gilead Sciences position peaked at $731M in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.